205. Fragile X syndrome related disease
3 clinical trials,   3 drugs   (DrugBank: 2 drugs),   21 drug target genes,   25 drug target pathways

Searched query = "Fragile X syndrome related disease", "Fragile X-associated tremor/ataxia syndrome", "FXTAS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02603926
(ClinicalTrials.gov)
October 20155/11/2015Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With AllopregnanoloneTreatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With AllopregnanoloneFragile X-associated Tremor/Ataxia SyndromeDrug: AllopregnanoloneRandi J. Hagerman, MDNULLCompleted50 Years85 YearsAll6Phase 2United States
2NCT02197104
(ClinicalTrials.gov)
January 201514/7/2014Citocoline for Treatment of FXTASPhase 2 Study of Citocoline for Treatment in Fragile X-associated Tremor/Ataxia SyndromeBalance and Cognitive Deficits in Fragile X-associated Tremor Ataxia SyndromeDrug: citocolineRush University Medical CenterNULLCompleted18 Years90 YearsAll10Phase 2United States
3NCT00584948
(ClinicalTrials.gov)
September 200722/12/2007Memantine Treatment in Fragile X-Associated Tremor/Ataxia SyndromeCharacterization and Treatment of CNS Abnormalities in Premutation Carriers: A Double-Blind Placebo-Controlled Trial of MemantineFragile X-Associated Tremor/Ataxia Syndrome;Fragile X Premutation CarriersDrug: Memantine;Drug: PlaceboUniversity of California, DavisNational Institute on Aging (NIA);Forest LaboratoriesCompleted30 Years80 YearsAll94N/AUnited States